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There is a wide variety of peptides released from food proteins which are able to exert a 23 
relevant benefit for human health like angiotensin-converting enzyme (ACE) inhibition, 24 
antioxidant, anti-inflammatory, hypoglucemic or antithrombotic activity, among others. 25 
This manuscript is reviewing the recent advances on enzymatic mechanisms for the 26 
hydrolysis of food proteins, including the types of enzymes and mechanisms of action 27 
involved, the strategies followed for the isolation and identification of bioactive 28 
peptides through advanced proteomic tools, the assessment of bioactivity and its 29 
beneficial effects. Specific applications in fermented and/or ripened foods where a 30 
significant number of bioactive peptides have been reported with relevant in vivo 31 
physiological effects on laboratory rats and humans, as well as the hydrolysis of food 32 
proteins for the production of bioactive peptides are also reviewed.  33 
 34 
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The content of proteins in foods is very significant and has a great nutritional relevance 40 
because they constitute the source of essential amino acids in the diet. However, 41 
proteins are subject of changes during food processing and cooking. In this sense, it is 42 
outstanding the relevant enzymatic hydrolysis of proteins taking place during food 43 
processing, especially during fermentation and/or ripening like in fermented sausages, 44 
dry-cured meats, cheese, yogurt, wine, etc., that generates polypeptides, peptides and 45 
free amino acids1-3. Such peptides are considered bioactive because, once released from 46 
the protein, they can contribute to a positive effect on consumers´ health. Numerous 47 
bioactive peptides have been reported in cheese4, meat products like fermented sausages 48 
and dry-cured ham5 and fishes6.  49 
The activity of the generated bioactive peptides has been extensively studied in vitro 50 
and its physiological effects confirmed through in vivo assays with laboratory animals 51 
and in recent trials with humans. The most reported bioactivities are ACE inhibitory, 52 
antioxidant, antimicrobial, opioid, inmunomodulating and antithrombotic. Milk-based 53 
products were the first reported to generate peptides with relevant bioactivity 54 
contributing to health7. Further, no changes in blood pressure were reported with daily 55 
consumption of Camembert cheese8 or even decreased diastolic and systolic blood 56 
pressure with Gouda-type cheese9. Similar trend in reduction of blood pressure was 57 
reported with daily consumption of dry-cured ham10 that was also reported to impair 58 
platelet and monocyte activation, and the levels of plasmatic P-selectin and interleukin 6 59 
in healthy humans11. Peptides from salmon and sardine were also reported to have 60 
antihypertensive effects in humans6. 61 
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Bioactive peptides can also be obtained in large amounts through reactor-controlled 62 
hydrolysis of extracted food proteins with commercial proteolytic enzymes or 63 
microorganisms12,13. Food by-products from meat, fish, dairy, olive oil and wine 64 
constitute typical sources of proteins to be hydrolysed and produce bioactive peptides at 65 
industrial scale12,14-17. Other hydrolyzates have been reported from eggs, peanut, and 66 
soybean proteins18-20. 67 
The possibility of diseases prevention through the ingesta of bioactive peptides is of 68 
high interest to health authorities because it would contribute to reduce the budget for 69 
health care treatments. However, bioavailability of bioactive peptides must be taken into 70 
account since some of them may be susceptible to partial or total loss of activity due to 71 
further hydrolysis by salivary, stomachal, intestinal and pancreatic enzymes, and even 72 
intestinal microbiota during gastrointestinal digestion21,22. Furthermore, peptides may be 73 
subject of reactivity (i.e. deamination, decarboxylation, oxidation, etc.) with the food 74 
matrix, being reduced its bioactivity and/or bioavailability23. 75 
This manuscript is reviewing the recent advances on the generation of bioactive 76 
peptides in fermented and ripened foods, the enzymatic mechanisms involved in the 77 
hydrolysis of food proteins, including the types of enzymes and mechanisms of action 78 
involved, the strategies followed for the isolation and identification of such peptides 79 
through advanced proteomic tools, the assessment of bioactivity and physiological 80 
effects, and specific applications. 81 
 82 
ROUTES FOR ENZYMATIC HYDROLYSIS OF FOOD PROTEINS 83 
Food proteins are subjected to hydrolysis during processing. Such proteolysis is more 84 
extensive when the food is fermented and/or ripened. The enzymes involved are either 85 
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intrinsically endogenous in the food (i.e. muscle enzymes in meat or fish), or microbial 86 
peptidases present in the microorganisms responsible for food fermentation (i.e. lactic 87 
acid bacteria peptidases in fermented sausages).  The enzymes responsible for 88 
proteolysis are endopeptidases, also known as proteinases, and exopeptidases. The 89 
mechanism of action consists of proteins break down by endopeptidases into 90 
polypeptides that constitute the substrates for the action of exopeptidases. In this way, 91 
polypeptides are further hydrolysed generating smaller peptides and free amino acids13. 92 
Depending on the length and sequence of residues, some of the released peptides may 93 
be bioactive24. Peptidomics has become a very useful tool for obtaining the peptide 94 
profiles of hydrolyzed foods and helpful for their identification and quantification25. 95 
There are many types of exopeptidases depending on the action on N- or C-terminal, its 96 
specificity and generated product of reaction. So, tripeptidylpeptidases (TPP) release 97 
tripeptides and dipeptidylpeptidases (DPP) release dipeptides from the N-terminal. DPP 98 
II and IV cleave preferently Gly-Pro and Arg-Pro, DPP III prefer dipeptides Ala-Arg 99 
and Arg-Arg while DPP I prefer Ala-Arg and Gly-Arg26. X-prolyl dipeptidyl peptidase 100 
(PepX) releases dipeptides X-proline in the N terminal. The generated tripeptides can be 101 
further hydrolysed by tripeptidases into a dipeptide and a single amino acid. Further, 102 
dipeptides can also be hydrolysed by dipeptidases into the two single constituent amino 103 
acids27. 104 
Free amino acids are also released from the N-terminal by several types of 105 
aminopeptidases (Pep N, Pep A, Pep C, Pep P among others). Amino acids can also be 106 
released from the C-terminal by carboxypeptidases A and B, named so because its 107 
activity is optimal at acid or basic pH, respectively. The consequence for the action of 108 
these enzymes is the generation of peptides with reduced length. A scheme of mode of 109 
action for different types of peptidases on a fragment of myosin heavy chain is shown in 110 
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Figure 1. For such particular case, it can be observed that endopeptidases act on the 111 
internal linkage Phe-Pro. Aminopeptidases would release Thr from the N-terminal that 112 
would be followed by the release of the dipeptide Val-Lys by a dipeptidylpeptidase. On 113 
the C-terminal, carboxypeptidase would release Asp and then Glu, followed by 114 
dipeptides Lys-Ile and Phe-Asp released by peptidyldipeptidase and Lys by 115 
carboxypeptidase28.  116 
The generation of bioactive peptides depends on the proteolysis phenomena but there 117 
are many variables affecting the enzyme action such as the food ingredients used, the 118 
type of enzymes and their activity, the microorganisms used for fermentation, and the 119 
applied processing conditions29. Preliminary information on the profile of expected 120 
small peptides may be obtained by using model systems representing the food. For 121 
instance, proteolysis was studied by using model fermented sausages inoculated with 122 
Lactobacillus curvatus CRL705 and Staphylococcus vitulinus GV31830.  123 
 124 
Hydrolysis in foods by endogenous and microbial peptidases and mode of action 125 
The hydrolysis of proteins in foods may be carried out by endogenous or microbial 126 
peptidases (see Figure 2). The released peptides may be bioactive but they must be 127 
resistant to gastrointestinal digestion and further hydrolysis by brush border peptidases 128 
in the intestine membrane in order to exert its physiological effect in humans31. 129 
Endogenous peptidases like muscle peptidases are able to release small peptides during 130 
the ripening and/or drying of meat products. So, DPP I and II that are active at pH 5.5-131 
6.5, near the pH found in most meat products, can release dipeptides Ala-Gln, Arg-Gly, 132 
Asn-Pro, lle-Leu, Ala-Gly, Ser-Gly, Ser-Gln, Pro-Ala among other from the N-133 
terminal32. TPP I, also active at pH 5.5-6.5, releases specific tripeptides like Ile-Ile-Pro, 134 
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Arg-Gly-Ala, Gly-Asn-Pro, Gly-Ala-Gly, Gly-Pro-Gly from the N-terminal33. Pro, Lys 135 
and Ala are also released by aminopeptidases34. Several antioxidant peptides were 136 
reported in different types of dry-cured ham (see Table 1). Some of them are Asp-Leu-137 
Glu-Glu in Xuanwei ham36, Gly-Lys-Phe-Asn-Val, Phe-Leu-Lys-Met-Asn, Gly-Lys-138 
Phe-Asn-Val and Leu-Pro-Gly-Gly-Gly-His-Gly-Asp-Leu in Jinhua ham35 and Ala-Glu-139 
Glu-Glu-Tyr-Pro-Asp-Leu38, Ser-Asn-Ala-Ala-Cys42 in Spanish ham and Met-Trp-Thr-140 
Asp and Phe-Trp-Ile-Ile-Glu in mutton ham39. ACE inhibitory peptides Leu-Gly-Leu, 141 
Gly-Val-Val-Pro-Leu and Ser-Phe-Val-Thr-Thr were isolated from Parma ham37 and 142 
Ala-Ala-Ala-Thr-Pro43 and Thr-Lys-Tyr-Arg-Val-Pro from Spanish ham42 were also 143 
reported. Peptides Ala-Ala-Ala-Ala-Gly, Ala-Leu-Gly-Gly-Ala and Leu-Val-Ser-Gly-144 
Met showed inhibitory activity against DPP IV and were also isolated from Spanish 145 
ham58. 146 
Most fermented foods today use microbial starters that improve safety and allow for a 147 
better standard quality. Such microorganisms have complex enzyme system exerting 148 
different types of activities able to hydrolyse proteins, carbohydrates and lipids59. 149 
Peptidases from lactic acid bacteria (LAB), yeasts or molds may be helpful in 150 
generating bioactive peptides, especially in short term processed foods60. LAB 151 
constitutes a large group of microorganisms typically used for food fermentation and 152 
characterized by having a high proteolytic activity as a consequence of their 153 
extracellular cell wall serine proteinase and the content of diverse intracellular 154 
peptidases with a wide range of specificity. This explains that different peptides patterns 155 
are obtained for a particular food depending on the LAB strain used for fermentation. 156 
Yeasts are also used in food fermentation and are able to hydrolyze proteins61.  157 
Proteinases A and D, and prolyl and arginyl aminopeptidases were reported in 158 
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Debaryomices hansenii61 and PepX, leucine aminopeptidase, and DPP IV and V in 159 
Aspergillus oryzae and DPP V in Aspergillus fumigatus62,63. 160 
Aminopeptidase activity is usually present in LAB so that its activity is particularly high 161 
in Leuconostoc mesenteroides and L. curvatus and variable between strains of L. 162 
plantarum, L. pentosus and Weissella cibaria64. Ala, Lys, Pro and Leu have been 163 
reported to be released from the N-terminal by strains of L. plantarum and L. brevis65. 164 
L. casei subsp casei is also able to release Ala, Arg, Lys, Met and Leu66-68. L. sakei 165 
releases Ala and Leu and L. plantarum releases Leu67,68. In general, aminopeptidases are 166 
partially inhibited by salt and therefore, their activity modulated in such fermented and 167 
ripened foods where salt is typically used69. There is a wide variety of intracellular 168 
aminopeptidases present in LAB as reported in the literature. So, aminopeptidase N, 169 
PepN is present in many bacteria like L. Helveticus, L. lactis and L. sakei, to release 170 
preferently Arg and Pro from the N-terminal70. Glutamyl (aspartyl) specific 171 
aminopeptidase PepA, that releases Glu and Asp from the N-terminal, is found in 172 
Streptococcus cremoris, Streptococcus thermophilus, L. lactis sp. and L. delbrueckii 173 
ssp. Lactis71. Aminopeptidase PepC is a thiol peptidase that hydrolyzes Ala, Leu or Lys 174 
from the N-terminal and has been reported in Streptococcus thermophilus and L. lactis 175 
ssp. Cremoris72. Proline aminopeptidase PepP that releases Arg, Met, Lys and Tyr at the 176 
N terminal is found in L. lactis ssp. Lactis73. 177 
The activity of carboxypeptidases to release amino acids from the C terminal has been 178 
reported to be very low or negligible in cell-free extracts of several LAB65,68 and low for 179 
the release of Phe and Arg by L. paracasei subsp paracasei66,67. On the contrary, 180 
carboxypeptidase activity in muscle foods is higher and, in fact, several amino acids like 181 
Phe, Tyr, Trp, Met, Ile, Leu, Val and Pro have been reported to be released from the C-182 
terminal by carboxypeptidases A and B during the processing of dry-cured ham33. 183 
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X-prolyl dipeptidyl peptidase PepX has been reported in Leuconostoc mesenteroides, L. 184 
curvatus and L. sakei64,70,74. Several tripeptides X-Pro-Pro were found in casein 185 
hydrolysates with L. helveticus70. Tripeptidase activity was reported for L. sakei and 186 
also by Pep N in LAB59,75. Generation of dipeptides through DPP action has been 187 
reported for L. paracasei where dipeptides like Ala-Phe, Pro-Leu, Lys-Leu, Leu-Gly 188 
and Lys-Phe were reported in fermented foods66. DPP activity has also been reported in 189 
Leuconostoc mesenteroides, releasing dipeptides Arg-Pro and Gly-Phe and L. paracasei 190 
subsp casei also releasing Gly-Pro67. It must be taken into account that the released 191 
dipeptides might be further hydrolysed into their individual amino acids by microbial 192 
dipeptidases activity. In fact, dipeptides can cross the membrane thanks to cellular 193 
transport systems and be further hydrolyzed by dipeptidases in L. sakei75. In such cases, 194 
the dipeptide is no longer bioactive and therefore no health benefits may be expected. 195 
Dipeptidase activity has been reported in microoorganisms like L. plantarum. L. brevis, 196 
L. helveticus, L. casei sp casei and L. paracasei. Their dipeptidases are able to 197 
hydrolyse preferently dipeptides Leu-Leu, Phe-Ala, but also dipeptides Ala-Phe, Tyr-198 
Leu and Lys-Leu, at lower rate. However, some dipeptides like Ala-Ala or Leu-Gly are 199 
resistant to hydrolysis68. Dipeptidase activity is also present in L. brevis that hydrolyzes 200 
dipeptides Leu-Leu, Tyr-Leu, Ala-Ala, Leu-Gly, Ala-Phe, Lys-Leu and Phe-Ala. Lower 201 
dipeptidase activity is also present in L. casei sp casei63,64,68. Oligopeptidase PepO is a 202 
metallopeptidase in Streptococcus thermophilus that is specific for peptides with 203 
arginine and methionine76,77. 204 
Furthermore, the net amount of bioactive peptides is a balance that does not only 205 
depend on peptides generation through hydrolysis but also on cells consumption. In 206 
LAB, the transportation of oligopeptides through the cell membrane consists of 5 207 
proteins (OppA, B, C, D and F). This system, typical of lactobacilli and lactococci, 208 
10 
 
allows the transport of peptide chains of up to 12 amino acids78. Streptococcus 209 
thermophilus has lower activity of peptidases but this is compensated by more efficient 210 
transport of peptide chains of up to 23 amino acids integrated in the Ami system77. 211 
Lactobacillus helveticus has been reported to hydrolyze Ƙ-casein and releases short 212 
peptides with a variety of bioactivities79. However, β-casein and αs1-casein found to be 213 
more resistant to hydrolysis probably due to the presence of phosphoserine in their 214 
respective structures80,81 even though several peptides were reported to be generated 215 
from such αs1-casein in Brazilian Canastra artisanal cheese
45 and hard cow milk 216 
cheese46. Resistance to proteolysis by L. acidophilus LA-5 was reported for αs2-casein
82. 217 
Other authors reported that the abundance of Pro, Leu and Val in β-casein, that are 218 
preferred by aminopeptidases and carboxypeptidases, was the probable reason for better 219 
hydrolysis than other types of caseins27. In fact, hexapeptides Ala-Val-Pro-Tyr-Pro-Gln 220 
and Glu-Ala-Met-Ala-Pro-Lys with antioxidant activity were released from β-casein 221 
after simulated gastrointestinal digestion of Stracchino cheese that is produced in 222 
Northern Italy22 and longer ACE inhibitory peptides in Brazilian Prato cheese47. A 223 
significant correlation between the release of ACE inhibitory peptides Val-Leu-Ser-224 
Arg-Tyr-Pro and Leu-Arg-Phe-Phe and aminopeptidase and carboxypeptidase activity 225 
was reported in milk fermented with the yeast Kluyveromyces marxianus Z1753. 226 
A recent research with L. helveticus LH-2 and L. acidophilus La-5 growing in whey 227 
protein isolate medium generated peptides with antivirulence effect against Salmonella 228 
enterica subsp. enterica serovar Typhimurium after growth. A large number of 229 
bioactive peptides, especially with ACE inhibitory activity were also reported to be 230 
generated for both strains83. The released peptides remained and accumulated in the 231 
media because they were not transported into the cells and thus were not further 232 
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hydrolysed due to their composition and low affinity to the oligopeptide-binding protein 233 
(OppA) of both strains83. 234 
When using staphilococci for meat fermentation, they have been reported to exert 235 
proteolytic activity preferently on myofibrillar meat proteins and peptidases action 236 
might also be expected84. Dry-fermented sausages with Lactobacillus pentosus and 237 
Staphylococcus carnosus containing added sodium caseinate as ingredient were 238 
reported to generate large amounts of bioactive peptides27. Both microorganisms, L. 239 
pentosus and S. carnosus are able to hydrolyze casein extracellularly thanks to the 240 
proteinase attached to the cell wall. The generated oligopeptides can be transported into 241 
the cell for further hydrolysis by intracellular peptidases into smaller peptides and free 242 
amino acids85.  243 
Hydrolysis of food proteins with commercial peptidases.  244 
Bioactive peptides are generally produced through the enzymatic hydrolysis of food 245 
proteins. Depending on the type of bioactivity searched, the protein source and degree 246 
of hydrolysis will be fixed86. Food proteins may be isolated and hydrolyzed in reactors 247 
using commercial peptidases or microorganisms with proteolytic activity in order to 248 
produce large amounts of bioactive peptides at industrial scale (see Figure 2). Typical 249 
commercial enzymes used for proteins hydrolysis are derived from cheap sources like 250 
microorganisms. This is the case of Alcalase from Bacillus licheniformis, Protamex 251 
from Bacillus sp., Flavorzyme from Aspergillus oryzae, Neutrase from Bacillus subtilis 252 
or Bacillus amyloliquefaciens, Bioprase from Bacillus sp., Thermolysin from Bacillus 253 
stearothermophilus, Prolidase from Lactobacillus casei, and Corolase 7089 from 254 
Bacillus subtilis, among other. Other enzymes may be obtained from animal and plant 255 
but the costs tend to be much higher. This is the case of trypsin from bovine or pig 256 
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pancreas, and bromelain from pineapple stem13. These enzymes have, in general, a 257 
broad specificity because they usually contain endopeptidases that can be combined 258 
with one or more exopeptidases87. An exception is Prolidase which is a dipeptidase88. 259 
Examples of food protein hydrolyzates, the enzymes and hydrolysis conditions used, the 260 
main obtained peptides and major assayed bioactivity are reported in Table 2. As can be 261 
observed in the table, most of the sequences of bioactive peptides contain less 10 amino 262 
acids residues. Longer peptides like those generated from the hydrolysis of spent hens99, 263 
duck100, goat milk103 or Spirulina platensis algae92 may be subject of further hydrolysis 264 
during gastrointestinal digestion. In general, the most usual recovered bioactivities are 265 
ACE inhibitory and antioxidant activity. In some cases, peptides with anti-inflammatory 266 
and antidiabetic activities are also obtained. Peptide Asp-Gly-Val-Val-Tyr-Tyr with 267 
outstanding ACE inhibitory activity, IC50=2 µM, was obtained through the fermentation 268 
of tomato seeds with Bacillus subtilis106. 269 
Defatted salmon backbones were hydrolysed with commercial enzymes obtaining 270 
protein hydrolysates with bioactivity. Hydrolysis with trypsin gave the highest ACE 271 
inhibitory, bromelain and papain gave the best cellular glucose transporter 272 
(GLUT/SGLT) inhibitory activity and the highest antioxidant activity was obtained 273 
hydrolyzing with protamex107. 274 
 275 
IDENTIFICATION OF BIOACTIVE PEPTIDES 276 
Traditionally, proteomics are used for the identification of proteins through the previous 277 
analysis of the peptides generated from their controlled hydrolysis using trypsin 278 
enzyme. This experimental methodology is called “bottom-up” approach and uses 279 
peptide mass fingerprint (PMF) for the final identification of the protein of origin. 280 
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However, the generation of bioactive peptides frequently occurs during the processing 281 
of foods or during gastrointestinal digestion, where the action of endogenous, microbial, 282 
or gastrointestinal enzymes results on unspecific peptide sequences that cannot be 283 
trypsin-digested due to their small size. Thus, the classic PMF approach, oftenly used in 284 
proteomics, is not useful, and it is thus necessary to adapt strategies used for the 285 
identification of proteins such as tandem mass spectrometry (MS) and modern 286 
bioinformatics tools108,109. 287 
In this sense, peptidomics would permit the identification of the peptides generated 288 
during different food processes or controlled hydrolysis although the identification of 289 
naturally generated peptides is very difficult because: (i) the analysis of  small bioactive 290 
peptides is near the limits of standard MS techniques, and (ii) longer peptides face up 291 
the difficulty to control hydrolysis. The major challenge is the complexity of the 292 
numerous peptides released and furthermore the associated difficulty due to the 293 
unspecific cleavage sites in proteins25.  294 
The identification of bioactive peptides from complex food matrices has been 295 
traditionally done using empirical approaches including (i) the release of bioactive 296 
sequences from the parent protein; (ii) a preliminary separation to screen the bioactivity 297 
using in vitro assays; (iii) a secondary purification and separation of the fractions 298 
showing the best bioactivity using high-resolution techniques; (iv) additional in vitro 299 
assays to determine the most active fractions; (v) identification of peptides included in 300 
those active fractions using MS in tandem; and (vi) the synthesis of the identified 301 
sequences in order to confirm their in vitro and in vivo bioactivity108. A scheme of the 302 
traditional empirical procedure followed for  bioactive peptides is shown in Figure 3. 303 
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 The development of this approach is very challenging as there are multiple factors to 304 
consider that could finally affect the generation of the bioactive peptides and it results 305 
very complicated when the objective is the generation of controlled sequences showing 306 
certain activity of interest.  In this case, the use of in silico approaches considering 307 
different bioinformatics tools for computer simulation results very useful and permits to 308 
choose/discard between different experimental procedures in a reasonable amount of 309 
time and low economical cost. In silico procedures will permit to select best protein of 310 
origin and proteolytic enzymes to obtain certain peptide sequences as well as predict 311 
their bioactivity, structure, and physical-chemical properties. After the simulation 312 
studies, the confirmation of in silico results is done through a traditional empirical 313 
approach110. Figure 4 shows the main steps followed for the identification of bioactive 314 
peptides through computational prediction. 315 
 316 
MAJOR BIOACTIVITIES OF RELEASED PEPTIDES 317 
The health benefits of fermented foods like antioxidant, antiinflammatory, 318 
antihypertensive, antidiabetic, antimicrobial, etc., are most times associated to the 319 
generated bioactive peptides as reported in the literature111. Tripeptides Val-Pro-Pro and 320 
Ile-Pro-Pro generated in fermented milk are well known for their high ACE inhibitory 321 
activity. A meta-analysis of the relevant literature on the effect of both tripeptides on 322 
blood pressure in humans was recently performed50 revealing that there was a 323 
significant but low hypotensive effect on blood pressure when those tripeptides were 324 
included in the diet. In fact, the observed effect was much lower than many 325 
antihypertensive drugs50. 326 
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The bioactivity of released peptides is always tested in vitro using different assays 327 
depending on the expected activity. However, in order to prove and confirm the 328 
bioactivity of the peptides, subsequent in vivo tests are done using cellular models, rat 329 
models, or even clinical trials with humans. In this regard, in vitro results do not 330 
guarantee a real physiological effect. Quite oftenly, peptides with a high bioactivity in 331 
vitro are inactive after oral administration112.  The reason is that, once ingested, peptides 332 
can be hydrolyzed by salivary, gastric and intestinal enzymes so that those peptides with 333 
longer sequences may be further hydrolyzed into smaller size peptides and therefore, 334 
loose their bioactivity. Small bioactive peptides can be hydrolyzed in the intestine by 335 
peptidases of the microbial flora or by brush border peptidases in the epithelium of the 336 
intestinal membrane. Finally, the released peptides have to cross the intestinal 337 
membrane and reach the bloodstream in order to exert its physiological benefit (see 338 
Figure 2).   339 
The bioactivity of the generated peptides also depends on the amino acid composition of 340 
the sequence and its size, but peptide structure and hydrophobicity also play an 341 
important role influencing the accessibility of the peptides to the active sites of the 342 
enzymes113. 343 
4.1 ACE-inhibitory peptides 344 
The ACE-inhibitory activity is the most extensively studied bioactivity in relation to 345 
food-derived peptides. Main interest is due to the ability of ACE-inhibitory peptides to 346 
prevent hypertension by decreasing the blood pressure. Its mechanism of action is based 347 
on the inhibition of ACE enzyme that converts the inactive decapeptide angiotensin-I 348 
into the potent vasoconstricting octapeptide angiotensin-II, whereas also inactivates the 349 
vasodilator bradykinin, resulting in an increase in blood pressure. Thus, by inhibiting 350 
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the catalytic action of ACE, the hypertension can be regulated by reducing the blood 351 
pressure in the body.  352 
Currently, thousands of potential ACE-inhibitory peptides have been isolated and 353 
identified from food products after fermentation or curing processes such as dry-cured 354 
ham, cheese, yogurt, and other fermented products, as well as from the controlled 355 
digestion using commercial enzymes such as trypsin, Corolase, Thermolysin, Alcalase, 356 
as well as controlled microbial fermentation, in food products such as fish, algae or 357 
meat. In this respect, Tables 1 and 2 show examples of bioactive peptides that have 358 
been described in the literature with respective calculated IC50 values.  However, the 359 
identification of ACE -inhibitory peptides is of high interest and other interesting 360 
sequences have been described in mushroom114, and cereals such as wheat, quinoa and 361 
corn115-117. 362 
4.2 Antioxidant peptides 363 
Antioxidant peptides are the second most studied group of food-derived peptides with 364 
biological activity. These peptides can act as antioxidants in foods, naturally protecting 365 
against oxidation, avoiding sensory and nutritional defects that are frequently associated 366 
with oxidative patterns. On the other hand, antioxidant peptides can also exert their 367 
function after ingestion in the human body, decreasing the negative effects of reactive 368 
oxygen species (ROS) and the risk for development of some degenerative diseases such 369 
as cardiovascular diseases or certain types of cancer118.  370 
The mechanism of action for antioxidant peptides can be very variable, depending on 371 
the transference mechanism. Certain mechanisms like ORAC and TRAP are based on 372 
hydrogen atom transfer mechanism while other such as DPPH and ABTS are based on 373 
electron transfer119. The antioxidant activity strongly depends on their composition in 374 
17 
 
amino acids. So, peptides containing His, Tyr, Met, Lys and Trp are more able to exert 375 
antioxidant activity.  376 
Carnosine and anserine are the two most abundant natural antioxidant peptides in foods, 377 
as they are very common in fish and meat products. However, many different peptides 378 
showing antioxidant activity have been described to be generated during the processing 379 
of some products such as dry-cured ham38,42,120, mutton ham49, cheese46, yogurt48, or 380 
fermented fish56. Also the use of commercial enzymes alone or in combination has 381 
resulted in extensive hydrolysis generating antioxidant peptides in algae, fish, legumes 382 
or meat as shown in Tables 1 and 2.   383 
4.3 Anti-obesity and antidiabetic peptides 384 
Obesity is the most important risk factor for type-2 diabetes, involves the accumulation 385 
of fat in the body, and it is associated to numerous health problems also related to 386 
cardiovascular diseases. Synthetic drugs are frequently used as anti-obesity substances 387 
with the disadvantage of showing multiple negative side effects. For this reason, the 388 
search for natural peptides derived from food sources is of high interest. Apolipoprotein 389 
A-I, melanocortin-4 receptor-specific agonist, GLP-1 dual and triple agonists, 390 
neuropeptides and prolactin-releasing peptide mimetics are the most studied for anti-391 
obesity properties121.  392 
On the other hand, diabetes mellitus is characterised by insufficient insulin production 393 
or insulin resistance, and the potential peptides that participate in the control of glucose 394 
level in carbohydrates pathway are α-amylase and α-glucosidase inhibitors, and 395 
dipeptidyl peptidase-IV inhibitors122.  396 
The most studied food-related peptides showing anti-obesity properties have been 397 
soybean peptides due to their body fat-decreasing characteristics123,124. On the other 398 
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hand, milk has been described to suppress appetite due to its content in satiating 399 
peptides, preventing weight gain and obesity. In this sense, camel milk peptides 400 
displayed novel antidiabetic and anti-obesity activity 125,126. Also peptides derived from 401 
the controlled digestion of algae have been described as antidiabetic (α-amylase 402 
inhibitory) and anti-obesity91,92,127. 403 
 4.4 Anti-inflammatory activity 404 
The inflammation is the response of the body to local injury or infection, where it is 405 
necessary to fight infection and repair the tissue. However, excessive and uncontrolled 406 
inflammation is often associated with chronic diseases 99,128,129.  407 
Anti-inflammatory peptides might participate in multiple physiological systems by 408 
modulating or regulating the inflammatory response. However, as food-derived 409 
bioactive peptides are ingested, the regulation of gastrointestinal system has been the 410 
most studied130. The oxidative stress is often associated with inflammatory processes. 411 
However, there are other complex mechanisms related to the renin-angiotensin-412 
aldosterone system (RAAS), proinflammatory cytokines, proinflammatory signalling 413 
kinases, and integrin-dependent signalling51. Anti-inflammatory peptides from milk, 414 
egg, fish and soy have been reported129,131,132. 415 
4.5 Antimicrobial activity 416 
Certain peptides are effective against certain bacteria like Staphylococcus aureus and 417 
Escherichia coli and yeasts. They can exert such antimicrobial activity by defending the 418 
organism against pathogens as well as in food by preventing its contamination. They 419 
can interact with the bacterial cells by nonreceptor-mediated or receptor-mediated 420 
mechanisms and invader cells by disturbing the membrane integrity133,134.  421 
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Antimicrobial peptides are generated during the processing of foods such as 422 
fermentation, and during controlled hydrolysis using commercial enzymes. They have 423 
been isolated from fish and marine products135,136, milk and milk products137,138, meat 424 
products40, legumes139 and eggs140. 425 
In summary, bioactive peptides can be generated either endogenously in food or through 426 
enzymatic hydrolysis of extracted food proteins. Depending on the particular food 427 
protein, a pool of peptides may be obtained. Those peptides with smaller size may be 428 
more bioaccessible and exhibit bioactivity that, depending on the sequence, can be 429 
either ACE inhibitory, antioxidant, antithrombotic, hypoglycemic, hypocholesterolemic, 430 
or antimicrobial among others. In any case, bioactive peptides must be bioavailable to 431 
exert its physiological action in the way that they must be resistant to gastrointestinal 432 
digestion and be able to be absorbed through the intestinal barrier and reach the 433 
bloodstream.  434 
 435 
ABBREVIATIONS USED 436 
ABTS: 2, 2′‐Azino‐bis (3‐ethylbenzothiazoline‐6‐sulfonic acid) radical scavenging 437 
assay; ACE: Angiotensin converting enzyme; β-CBA: β-carotene bleaching activity; 438 
Ch: Fe2+-chelating activity; DPP: dipeptidylpeptidases; DPPH: 2, 2‐diphenyl‐1‐picryl‐439 
hydrazyl  radical scavenging activity; LAB: Lactic acid bacteria; MS: mass 440 
spectrometry; ORAC: oxygen radical absorbance capacity; PMF: peptide mass 441 
fingerprint; RAAS: renin-angiotensin-aldosterone system; ROS: Radical oxygen 442 
species; RP: reducing power; TRAP: total radical trapping antioxidant parameter; 443 
DPPH: radical scavenging activity; TPP: tripeptidylpeptidases.  444 
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Three letter abbreviations for amino acids are used. Ala: Alanine; Arg: Arginine; Asn: 445 
Aspargine; Asp: Aspartic Acid; Cys: Cysteine; Gln: Glutamine; Glu: Glutamic acid; 446 
Gly: Glycine; His: Histidine; Ile: Isoleucine; Leu: Leucine; Lys: Lysine; Met: 447 
Methionine; Phe: Phenyl alanine; Pro: Proline; Ser: Serine; Thr: Threonine; Trp: 448 
Tryptophan; Tyr: Tyrosine; Val: Valine. 449 
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LEGENDS FOR THE FIGURES 924 
 925 
Figure 1.- Scheme of food protein hydrolysis and enzymes involved. The amino acids 926 
sequence is a fragment belonging to myosin heavy chain. Aminopeptidase (A), 927 
Dipeptidylpeptidase (D), Endopptidase (E), Carboxypeptidase (C) and 928 
Peptidylpeptidase (P). Adapted from (29). 929 
 930 
 931 
Figure 2.- Scheme of the generation of bioactive peptides from protein hydrolysis in 932 





Figure 3.- Scheme of the traditional empirical procedure for the identification and 936 
confirmation of bioactive peptides from food matrices. SEC: size-exclusion 937 
chromatography; CE: capillary electrophoresis; LC: liquid chromatography; IEF: 938 
isolectric focusing; HPLC: high performance liquid chromatography; MS/MS: mass 939 
spectrometry in tandem. Adapted from (84). 940 
 941 
 942 
Figure 4.- Main steps of in silico approaches and open access databases for the selection 943 
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Food Type / Fermentation Peptide sequence Parent protein Potential activity Activity values* Reference 
Dry-cured ham Chinese Jinhua FLKMN — Antioxidant DPPH: 70% at 1 mg/mL 35 
GKFNV — Antioxidant DPPH: 92.7% at 1 mg/mL 35 
LPGGGHGDL — Antioxidant OH-: 85% at 1 mg/mL 35 
Chinese Xuanwei DLEE — Antioxidant DPPH: 74.4%  at 0.5 mg/mL 36 
Italian Parma GVVPL — Antihypertensive ACE inhibition: IC50 = 956 µM 37 
LGL — Antihypertensive ACE inhibition: IC50 = 145 µM 37 
SFVTT — Antihypertensive ACE inhibition: IC50 = 395 µM 37 
Spanish AEEEYPDL Creatine kinase Antioxidant ABTS: 1474.08 nmol TEAC/mg, ORAC: 960.04 nmol TE/mg 38 




PAF-AH: 26.06 % at 1mM 39 
Antihypertensive 68.34% at 1mM 39 
HCNKKYRSEM  Dynein heavy chain Antimicrobial MIC (L. monocytogenes)= 50 mM 40 
Anti-
inflammatory 
LOX: 23.33% at 1mM 41 
45 
 
Antioxidant ORAC: 1767.56 nmol TE/mg 41 
Antihypertensive ACE inhibition: 99.34% at 1 mM 41 
MDPKYR Titin Antimicrobial MIC (L. monocytogenes)= 50 mM 40 
Anti-
inflammatory 
PAF-AH: 13.48% at 1mM, ATX: 14.51% at 1mM 41 
Antioxidant ABTS: 5444.3 nmol TEAC/mg, ORAC: 3087.5 nmol TE/mg  41 
Antihypertensive ACE inhibition: 60.64% at 1mM 41 
SNAAC Myosin heavy chain Antioxidant ABTS: 3097.04 nmol TEAC/mg, ORAC: 2737.4 nmol TE/mg 42 
TKYRVP Titin Anti-
inflammatory 
PAF-AH: 11.04% at 1mM, ATX: 22.47% at 1mM 41 
Antioxidant ABTS: 6987.8 nmol TEAC/mg, ORAC: 2886.8 nmol TE/mg 41 





ACE inhibition: IC50 = 100,00 µM 
 
43 
TSNRYHSYPWG Ser/Thr-protein kinase Anti-
inflammatory 
PAF-AH: 16.30 % at 1mM, ATX:18.93% at 1mM 41 
Antioxidant ABTS: 3036.03 nmol TEAC/mg 41 
Antihypertensive ACE inhibition: 71.62% at 1mM 41  
Mutton ham   MWTD — Antioxidant ABTS: IC50 = 0.4 mg/mL 44 
  APYMM — Antioxidant ABTS: IC50 = 0.12 mg/mL 44 
  FWIIE — Antioxidant ABTS: IC50 = 0.23 mg/mL 44 
46 
 
Cheese Italian Stracchino  AVPYPQ β-Casein Antioxidant ABTS: 19.5 µmol TE/mg 22 
EAMAPK  β-Casein Antioxidant ABTS: 22.9 µmol TE/mg 22 
Brazilian Canastra artisanal Minas RPKHPIKHQ αS1-Casein Antimicrobial MIC (E. coli)= 15 µg/mL 45 
RPKHPIKHQG αS1-Casein Antimicrobial MIC (E. coli)= = 17 µg/mL 45 
Hard cow milk cheese  EIVPN αS1-Casein Antioxidant DPPH inhibition, Metal chelating activity 46 
DKIHPF β-Casein Antioxidant DPPH inhibition, Metal chelating activity 46 
VAPFPQ αS1-Casein Antioxidant Metal chelating activity 46 
Brazilian Prato / Lactobacillus 
helveticus (10%, 40°C, 18h) 
QEPVLGPVRGPFPIIV β-Casein Antihypertensive ACE inhibition 47 
YQEPVLGPVRGPFP β-Casein Antihypertensive ACE inhibition 47 
Yoghurt Chinese Feng Wei Suan Ru / 
Streptococcus thermophellolus + 
Lactobacilus bulgaricus 
FVAPFPEVF αs1-Casein Antidiabetic DPP-IV inhibition: IC50 = 2.52 µM 48 
  Antihypertensive ACE inhibition: IC50 = 35.76 µM 48 
  PPFLQPEVM β-Casein Antidiabetic DPP-IV inhibition: IC50 = 0.44 µM 48 
  Antihypertensive ACE inhibition: IC50 = 34.63 µM 48 
  QEPVLGPVRGPFPIIV β-Casein Antihypertensive ACE inhibition: IC50 = 160.76 µM 48 
  Probiotic yoghurt with pineapple 
peel / S. thermophilus + L. 
SLPQNIPPLTQTPVVVPPF β-Casein Antioxidant ABTS: IC50 = 1.44 mg/mL, OH
-: 34.97% at 1 mg/mL 49 
47 
 
  bulgaricus + L. acidophilus + L. 
casei + L. paracasei (1%, 42°C, pH 
4.5) 
Anticancer Antiproliferation colon cancer cells: 38.55% at 3 mg/mL 49 
  YQEPVLGPVRGPFPIIV β-Casein Antioxidant ABTS: IC50 = 29.88 µg/mL 49 
  Anticancer Antiproliferation colon cancer cells: 41.49% at 3 mg/mL 49 
Fermented milk Lactobacillus, Saccharomyces  IPP, VPP β-Casein Antihypertensive  SBP: -2.95 mmHg 50 
    Anti-
inflammatory 
Suppression of cytokine mediated inflammatory responses 51 
      Adipogenic Insulin-mimetic adipogenic effects  51 
      Antidiabetic Insulin sensitizing actions in adipocytes 52 
  Kluyveromyces marxianus (6%, 
32°C, pH 6.5, 48h) 
LRFF κ-Casein Antihypertensive ACE inhibition: IC50 = 116.9 µM 53 
  VLSRYP αS1-Casein Antihypertensive ACE inhibition: IC50 = 36.7 µM 53 
  Kombucha culture (1%, 37°C, 72h) FVAPEPFVFGKEK αS1-Casein Antihypertensive ACE inhibition: IC50 = 0.75 µM 54 
  LVYPFPGPLH β-Casein Antihypertensive ACE inhibition: IC50 = 0.03 µM 54 
  VAPFPEVFGK αS2-Casein Antihypertensive ACE inhibition: IC50 = 0.03 µM 54 
  L.actobacillus casei (1%, 37°C, 
72h) 
LVESPPELNTVQ κ-Casein Antihypertensive ACE inhibition: IC50 = 0.11 µM 54 
  VLESPPELN κ-Casein Antihypertensive ACE inhibition: IC50 = 0.23 µM 54 
  WGYLAYGLD — Antihypertensive ACE inhibition: IC50 = 0.10 µM 54 
48 
 
Fermented cucumber pickles Lactobacillus pentosus (28°C, 43d) IPP — Antihypertensive ACE inhibition: IC50 = 5 µM 55 
  KP — Antihypertensive ACE inhibition: IC50 = 22 µM 55 
  LPP — Antihypertensive ACE inhibition: IC50 = 9.6 µM 55 
  VPP — Antihypertensive ACE inhibition: IC50 = 9 µM 55 
Fermented fish Malaysian pekasam / Lactobacillus 
plantarum (27°C, 15d) 
AIPPHPYP  — Antioxidant IC50 (mg/mL): DPPH = 1.38, ABTS = 0.87, RP = 0.45 56 
IAEVFLITDPK — Antioxidant IC50 (mg/mL): DPPH = 0.89, ABTS = 0.594, RP = 0.69 56 
Fermented shrimp pastes Thai Kapi Ta Dam IF — Antihypertensive ACE inhibition: IC50 = 70.03 µM 57 
Thai Kapi Ta Dam, Kapi Ta Deang SV — Antihypertensive ACE inhibition: IC50 = 60.68 µM 57 
WP — Antioxidant ABTS: EC50 = 17.52 µM 57 
* Activity values: IC50 value is the peptide concentration that inhibits 50% of activity. SBP is the maximum decrease in systolic blood pressure after administration of the peptides to human subjects. Antioxidant activity: ABTS  
radical-scavenging activity (ABTS), DPPH radical scavenging assay (DPPH), hydroxyl radical scavenging activity (OH-), and oxygen radical absorbance capacity assay (ORAC). MIC is the minimum concentration of peptide that inhibits 








Table 2.- Examples of bioactive peptides recently identified in hydrolyzates of different types of foods. 951 
            
  
  




Trypsin (2%, 2h) FQIN[M(O)]CILR — Antihypertensive ACE inhibition: IC50 = 9.64 μM, SBP: -34 
mmHg (2h) 
89 
TGAPCR — Antihypertensive ACE inhibition: IC50 = 23.94 μM, SBP: -
28 mmHg (2h) 
89 
Palmaria palmata Corolase PP (2%, 50°C, pH 7, 4h) SDITRPGGQM Allophycocyanin 
β-chain 
Antioxidant ORAC: 152.43 nmol TE/μmol, RP: 21.23 
nmol TE/μmol 
90 
Red seeweed (Porphyra 
spp) 
Pepsin (1%, 37°C, pH 2, 3h) GGSK — Antidiabetic α-Amylase inhibition: IC50 = 2.58 mM 91 
ELS — Antidiabetic α-Amylase inhibition: IC50 = 2.62 mM 91 
Spirulina platensis Pepsin (6%, 37°C, pH 2, 10h) CANPHELPNK — Anti-obesity Antiproliferation adypocites: 60.08% at 2 
mg/mL 
92 
Triglyceride accumulation: -19.5% at 600 
μg/mL 
92 
LNNPSVCDCDCMMKAAR — Anti-obesity Antiproliferation adypocites: 32.29% at 2 
mg/mL 
92 
NALKCCHSCPA — Anti-obesity Antiproliferation adypocites: 37.86% at 2 
mg/mL 
92 
NPVWKRK  Hydrolase protein Anti-obesity Antiproliferation adypocites: 46.89% at 2 
mg/mL 
92 
Triglyceride accumulation: -23.7% at at 
600 μg/mL 
92 
Fish Atlantic salmon (Salmo 
salar) 
Corolase PP (1%, 50°C, pH 7, 1h) GPAV — Antihypertensive ACE inhibition: IC50 = 415.91 μM 93 
Antidiabetic DPP-IV inhibition: IC50 = 245.58 μM 93 
Antioxidant ORAC: 9.51 μmol TE/μmol 93 
50 
 
FF — Antihypertensive ACE inhibition: IC50 = 59.151 μM 93 
Antidiabetic DPP-IV inhibition: IC50 = 546.84 μM 93 
Antioxidant ORAC: 8.47 μmol TE/μmol 93 
Cuttlefish (Sepia 
officinalis) 
Bacillus mojavensis (3U/mg, 
50°C, pH 10) 
AFVGYVLP — Antihypertensive ACE inhibition: IC50 = 18.02 μM 94 
Cuttlefish hepatopancreas 
enzymes           (3U/mg, 50°C, pH 
8) 
EKSYELP — Antihypertensive ACE inhibition: IC50 = 14.41 μM 94 





Insoluble bromelain (0.5%, 50°C, 
2h) 
AER — Antihypertensive ACE inhibition: IC50 = 0.11 g/L 95 
EQIDNLQ — Antihypertensive ACE inhibition: IC50 = 0.24 g/L 95 
Insoluble papain (0.5%, 50°C, 6h) DPHI — Antihypertensive ACE inhibition: IC50 = 0.02 g/L 95 
EPLYV — Antihypertensive ACE inhibition: IC50 = 0.05 g/L 95 
Insoluble flavourzyme (1.25%, 
50°C, 2h) 





ITALAPSTM Actin Antihypertensive ACE inhibition: IC50 = 0.23 mM 96 
Antioxidant β-CBA: IC50 = 0.64 mM 96 
SLEAQAEKY Tropomyosin  Antihypertensive ACE inhibition: IC50 = 0.41 mM 96 
Antioxidant RP, ORAC 96 
GTEDELDKY Tropomyosin  Antioxidant DPPH: IC50 = 1.32 mM, RP, ORAC 96 
Bacillus subtilis (4%, 37°C, 24h) NVPVYEGY Actin Antihypertensive ACE inhibition: IC50 = 0.21 mM 96 
51 
 
Antioxidant DPPH: IC50 = 1.41 mM, RP, ORAC 96 
Pacific herring (Clupea 
pallasii) 
Trypsin (1.39U/Kg, 32.06°C, pH 
6.78, 7h) 
KEEKFE — Antioxidant IC50 (mg/mL): OH
-= 3.78, DPPH = 4.37, 
Cell = 1.04 
97 
LHDELT — Antioxidant IC50 (mg/mL): OH
-= 4.57, DPPH = 5.14, 
Cell = 1.19 
97 
Legumes Soy Alkaline proteinase (6U/Kg, 50°C, 
pH 9) 
LLPLPVLK — Antidiabetic α-Glusosidase inhibition: IC50 = 237.43 
μM 
97 
SWLRL — Antidiabetic α-Glusosidase inhibition: IC50 = 182.05 
μM 
97 





Alcalase (0.5%, 50°C, pH 8.3, 2h) CCGDYY — Antioxidant ABTS: 1.18 μmol TE/μmol, ORAC: 3.61 
μmol TE/μmol 
98 
DGLGYY — Antioxidant ABTS: 0.63 μmol TE/μmol, ORAC: 3.83 
μmol TE/μmol 
98 
GESWCR — Antioxidant ABTS: 1.12 μmol TE/μmol, ORAC: 2.43 
μmol TE/μmol 
98 
SQLPGW — Antioxidant ABTS: 0.53 μmol TE/μmol, ORAC: 2.95 
μmol TE/μmol 
98 
WAL — Antioxidant ABTS: 0.58 μmol TE/μmol, ORAC: 3.38 
μmol TE/μmol 
98 
YDLHGY — Antioxidant ABTS: 0.64 μmol TE/μmol, ORAC: 3.59 
μmol TE/μmol 
98 
Mea Spent hens Protex 50FP (4%, 50°C, pH 3, 3h) AFMNVKHWPW Myosin Anti-inflammatory IL-6 inhibition: 59% at 100 μg/mL 99 
FLWGKSY Myomesin Anti-inflammatory IL-6 inhibition: 79% at 100 μg/mL 99 
SFMNVKHWPW Myosin Anti-inflammatory IL-6 inhibition: 68% at 100 μg/mL 99 
WPW Myosin Anti-inflammatory IL-6 inhibition: 63% at 100 μg/mL 99 
Duck (Anas 
platyrhynchos) 
Protamex (0.75%, 50°C, pH 6, 4h) AGRDLTDYLMKIL — Antioxidant DPPH: 85.45%, OH-= 30.75%, Fe-




GYDLGEAEFARIM — Antioxidant DPPH: 91.81%, OH-= 31.30%, Fe-
Ch=58.94% at 1mg/mL 
100 
IEDPFDQDDWGAWKK — Antioxidant DPPH: 90.39%, OH-= 46.51% at 1mg/mL 100 
LQAEVEELRAALE — Antioxidant DPPH: 93.36%, OH-= 20.52%,Fe-
Ch=87.13% at 1mg/mL 
100 
NWDDMEK — Antioxidant DPPH: 16.36%, OH-= 43.34%,Fe-
Ch=37.20% at 1mg/mL 
100 
Kacang goat (Capra 
aegagrus hircus) 
Protamex + Flavourzyme (0.5%, 
50°C,  pH 7, 4h) 
FQPS Actin Antihypertensive ACE inhibition: IC50 = 27.0 μM, SBP: -
10.6 mmHg (8h) 
101 
Pork loin Thermolysin (0.008%, 5°C, 24h) LVGRPRHGQ — Antihypertensive ACE inhibition: IC50 = 15.69 μM 102 
VFPS — Antihypertensive ACE inhibition: IC50 = 3.60 μM 102 
Milk Goat (Capra hircus) 
milk 
Trypsin (3%, 37°C, pH 8, 3h) INNQFLPYPY κ-Casein Antidiabetic DPP-IV inhibition: IC50 = 40.08 μM 103 
MHQPPQPL β-Casein Antidiabetic DPP-IV inhibition: IC50 = 350.41 μM 103 
SPTVMFPPQSVL β-Casein Antidiabetic DPP-IV inhibition: IC50 = 376.31 μM 103 
By-
products 
Chicken combs and 
wattles 
Alcalase (5%, 4h) APGLPGPR Collagen and 
elastin 
Antihypertensive ACE inhibition: IC50 = 53 μM 104 
FPGPPGP Collagen and 
elastin 
Antihypertensive ACE inhibition: IC50 = 38 μM 104 
Piro-GPPGPT Collagen and 
elastin 
Antihypertensive ACE inhibition: IC50 = 88 μM 104 
Oil palm  (Elaeis 
guineensis Jacq) kernel 
expeller 
Alcalase (0.5%, 45°C, pH 8.5, 2h) 
+ flavourzyme (0.5%, 50°C, pH 7, 
2h) + pepsin (0.3%, 37°C, pH 2, 
1h)+ trypsin (0.3%, 37°C, pH 7, 
1h). 
ADVFNPR Glutelin-2 Antihypertensive ACE inhibition: IC50 = 485.7 μM 105 
LPILR Glutelin-2 Antihypertensive ACE inhibition: IC50 = 779.8 μM 105 
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VIEPR Glutelin-2 Antihypertensive ACE inhibition: IC50 = 632.0 μM 105 
VVLYK Glutelin-2 Antihypertensive ACE inhibition: IC50 =533.9 μM 105 
Tomato seeds Bacillus subtilis (2%, 37°C, 24h) DGVVYY  — Antihypertensive ACE inhibition: IC50 = 2 μM 106 
GQVPP — Antioxidant DPPH: 97% at 0.4mM, RP: 0.95 UA at 
0.5 mM 
106 
* Activity values: IC50 value is the peptide concentration that inhibits 50% of activity. SBP is the maximum decrease in systolic blood pressure after administration of the peptide to spontaneously hypertensive rats. 
Antioxidant activity: ABTS radical-scavenging activity (ABTS), 
Radical scavenging assay (DPPH), hydroxyl radical scavenging activity (OH-), β-carotene bleaching activity (β-CBA), reducing power (RP), oxygen radical absorbance capacity assay (ORAC), cytotoxic effects on HepG2 
cells (Cell), and Fe2+-chelating activity (Ch).  
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